The recent partnership of Cancer Treatment Centers of America (CTCA) with Allscripts and Nanthealth will create powerhouse treatment options. This collaboration will bring a new face to cancer treatment and the technology utilized to help patients. Their program will be called Clinical Pathways and there are some major benefits to its implementation.
The first is that oncologists can customize treatment options and plans. The technology will help doctors consider the type of disease they have and the state they are in. It will also allow for comparing treatments on multiple levels, including cost. The program works in real time and stays up to date with all guidelines, toxicity ratings, and other findings.
This program at the doctor’s’ fingertips will help streamline treatment for cancers and allow doctors to focus on the best treatment options for the patients. The efficiency of Clinical Pathways will keep patients, their treatments, and all risks and costs updated. Clinical Pathways also keeps doctors up to date on the latest findings in cancer care so they can provide the very best and most updated treatment options.
The Clinical Pathways integration is a huge step in cancer treatment for CTCA. And the partnership of CTCA with Nantech and Allscripts means big things in the cancer treatment community.
Cancer Treatment Centers of America is a network of five hospitals that specialize in cancer treatment of adult patients. CTCA utilizes the most up to date and effective cancer treatment practices including chemotherapy, radiation, surgery, genomic testing, among others.
The CTCA hospitals are located in Chicago, Philadelphia, Phoenix, Tulsa, and Atlanta. The doctors and staff at CTCA pride themselves in helping you, as an individual, conquer your unique fight against cancer. This makes them the name to trust in patient centered approaches to treatment.
For more information follow CTCA on Twitter @CTCA